BPC-157 5mg + TB-500 5mg Blend
Purity: ≥98%
$85.00
≥98%HPLC Purity
COAIncluded
USAShipped
AOD-9604 + Tesamorelin + MOTS-c Blend Peptide
Triple-peptide research blend combining AOD-9604, Tesamorelin, and MOTS-c for multi-pathway metabolic research protocols.
$95.00
Quick Facts
| SKU | ACR-BL-ATM |
|---|---|
| Sequence | Multi-peptide blend |
| Purity | ≥97% |
| Physical Form | Lyophilized Powder |
| Storage | Store at -20°C. |
About the AOD-9604 + Tesamorelin + MOTS-c Research Blend
This triple-peptide blend combines three compounds studied in metabolic pathway research: AOD-9604 (hGH fragment 176-191, beta-3 adrenergic receptor interaction), Tesamorelin (modified GHRH analog, GHRH receptor activation), and MOTS-c (mitochondrial-derived peptide, AMPK activation).
Each component targets a distinct metabolic signaling node: AOD-9604 acts on adipose tissue adrenergic signaling, Tesamorelin activates pituitary GH release pathways, and MOTS-c modulates cellular energy sensing via AMPK. The combination is studied for potential multi-pathway metabolic investigation.
For laboratory research use only.
Frequently Asked Questions
What is the AOD + Tesamorelin + MOTS-c blend?
This triple blend combines AOD-9604 (beta-3 adrenergic signaling), Tesamorelin (GHRH receptor), and MOTS-c (AMPK activation) — three peptides targeting distinct metabolic pathways. For research use only.
For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.